Page results
-
This year’s UCLH Charity Christmas card has been especially designed for us by artist and supporter Alex Echo. The colourful, striking design is a contemporary take on the festive season.
-
The COVID Medicines Delivery Unit (CMDU gives new COVID-19 treatments for patients at highest risk in the community from the NCL sector. These treatments involve intravenous infustion of neutralising monoclonal antibodies (nMABs) or oral antiviral treatments, which are given to high-risk patients who have had a positive PCR test.
-
David Probert has been granted honorary professor status at UCL’s new Global Business School for Health (GBSH).
-
UCLH has teamed up with Air Ambulance Kent Surrey Sussex (KSS) to create an additional module to its Airway Matters, Massive Open Online Course (MOOC).
-
This page provides information about a new way of diagnosing and treating disorders of the pancreas, pancreatic duct and bile ducts.
-
The Carbs & Cals app is moving to a subscription-based service.
-
Information for patients (or anyone who is involved in their care) who have undergone implantation of an Intrathecal Baclofen Pump under the care of the team at this hospital.
-
This page is for parents, carers and family members who are acting as comforters and carers for children and young people having radioactive iodine (131I) treatment. It explains what the treatment involves, how to prepare for it and what you can expect afterwards.
-
UCLH is to work in partnership with University Hospitals Birmingham NHS Foundation Trust in a major digital health initiative in which researchers use data collected in acute care settings to improve patient care.
-
UCLH is pleased to announce the appointment of two new non-executive directors to the board
File results
-
FOI/2022/0275 - Biologic medications within dermatology
-
FOI/2022/0576 - Medications within dermatology
-
FOI/2023/0210 - Top five drugs that expired by value
-
FOI/2023/0323 - Medications/ treatment for dermatology and respiratory medicine
-
FOI/2023/0670 - Treatment with immunomodulatory medications
-
FOI/2024/0013 - Medications within dermatology and respiratory medicine
-
FOI/2024/0156 - Value licensing - Microsoft software assets
-
FOI/2024/0415 - Biologic and targeted medications within dermatology medicine
-
FOI/2024/0721 - New biologic and targeted medications/ treatment within dermatology